B-type natriuretic peptide secretion without change in intra-cardiac pressure

Standard

B-type natriuretic peptide secretion without change in intra-cardiac pressure. / Puelacher, Christian; Rudez, Jasna; Twerenbold, Raphael; Moreno Weidmann, Zoraida; Osswald, Stefan; Eckstein, Friedrich; Lurati-Buse, Giovanna; Pargger, Hans; Mueller, Christian.

in: Clinical Biochemistry, Jahrgang 48, Nr. 4-5, 01.03.2015, S. 318-321.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Puelacher, C, Rudez, J, Twerenbold, R, Moreno Weidmann, Z, Osswald, S, Eckstein, F, Lurati-Buse, G, Pargger, H & Mueller, C 2015, 'B-type natriuretic peptide secretion without change in intra-cardiac pressure', Clinical Biochemistry, Jg. 48, Nr. 4-5, S. 318-321. https://doi.org/10.1016/j.clinbiochem.2014.12.010

APA

Puelacher, C., Rudez, J., Twerenbold, R., Moreno Weidmann, Z., Osswald, S., Eckstein, F., Lurati-Buse, G., Pargger, H., & Mueller, C. (2015). B-type natriuretic peptide secretion without change in intra-cardiac pressure. Clinical Biochemistry, 48(4-5), 318-321. https://doi.org/10.1016/j.clinbiochem.2014.12.010

Vancouver

Bibtex

@article{275a9583aec94b9e8e0a6ab1ef5615a7,
title = "B-type natriuretic peptide secretion without change in intra-cardiac pressure",
abstract = "Objective: In clinical cardiology, B-type natriuretic peptide (BNP) is used as a non-invasive surrogate marker for intra-cardiac filling pressures, particularly in patients with heart failure. It is unknown whether and to what extent increase in intravascular volume and/or sympathetic tone while maintaining constant intra-cardiac pressures leads to an increase in levels of BNP in vivo. Design and Methods: We aimed to test this hypothesis in an experimental in vivo model of patients directly after off-pump coronary artery bypass grafting admitted to the intensive care unit. These patients require high volumes of intravenous fluids titrated to keep intra-cardiac filling pressures and arterial blood pressure in the normal range while awakening from deep general anesthesia. In 27 consecutive patients, intra-cardiac filling pressures (using a pulmonary artery catheter) and levels of BNP were measured simultaneously every 6. h. Results: At 0, 6, 12, and 18. h, the pulmonary capillary wedge pressure remained constant (12. ±. 4, 13. ±. 3, 12. ±. 3, and 13. ±. 3. mmHg, respectively; p=. 0.351). Similarly, right heart filling pressures did not change during the study period. In contrast, BNP levels increased significantly during the study period: Median levels were 82 [IQR 37-162] pg/ml at 0. h, 153 [92-246] pg/ml at 6. h, 274 [156-392] pg/ml at 12. h, and 320 [200-528] pg/ml at 18. h (. p<. 0.001). No significant correlation between BNP levels and pulmonary capillary wedge pressures was found (. r=. 0.052; p=. 0.604). Conclusions: After cardiac surgery, BNP cannot be considered a reliable non-invasive surrogate for PCWP. In vivo, substantial BNP secretion occurs independently of PCWP in a setting of increasing intravascular volume and consciousness/sympathetic tone.",
keywords = "BNP, Cardiac surgery, Endocrinology, Intra-cardiac pressure, Volume",
author = "Christian Puelacher and Jasna Rudez and Raphael Twerenbold and {Moreno Weidmann}, Zoraida and Stefan Osswald and Friedrich Eckstein and Giovanna Lurati-Buse and Hans Pargger and Christian Mueller",
note = "Publisher Copyright: {\textcopyright} 2014 Elsevier Inc.",
year = "2015",
month = mar,
day = "1",
doi = "10.1016/j.clinbiochem.2014.12.010",
language = "English",
volume = "48",
pages = "318--321",
journal = "CLIN BIOCHEM",
issn = "0009-9120",
publisher = "Elsevier Inc.",
number = "4-5",

}

RIS

TY - JOUR

T1 - B-type natriuretic peptide secretion without change in intra-cardiac pressure

AU - Puelacher, Christian

AU - Rudez, Jasna

AU - Twerenbold, Raphael

AU - Moreno Weidmann, Zoraida

AU - Osswald, Stefan

AU - Eckstein, Friedrich

AU - Lurati-Buse, Giovanna

AU - Pargger, Hans

AU - Mueller, Christian

N1 - Publisher Copyright: © 2014 Elsevier Inc.

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Objective: In clinical cardiology, B-type natriuretic peptide (BNP) is used as a non-invasive surrogate marker for intra-cardiac filling pressures, particularly in patients with heart failure. It is unknown whether and to what extent increase in intravascular volume and/or sympathetic tone while maintaining constant intra-cardiac pressures leads to an increase in levels of BNP in vivo. Design and Methods: We aimed to test this hypothesis in an experimental in vivo model of patients directly after off-pump coronary artery bypass grafting admitted to the intensive care unit. These patients require high volumes of intravenous fluids titrated to keep intra-cardiac filling pressures and arterial blood pressure in the normal range while awakening from deep general anesthesia. In 27 consecutive patients, intra-cardiac filling pressures (using a pulmonary artery catheter) and levels of BNP were measured simultaneously every 6. h. Results: At 0, 6, 12, and 18. h, the pulmonary capillary wedge pressure remained constant (12. ±. 4, 13. ±. 3, 12. ±. 3, and 13. ±. 3. mmHg, respectively; p=. 0.351). Similarly, right heart filling pressures did not change during the study period. In contrast, BNP levels increased significantly during the study period: Median levels were 82 [IQR 37-162] pg/ml at 0. h, 153 [92-246] pg/ml at 6. h, 274 [156-392] pg/ml at 12. h, and 320 [200-528] pg/ml at 18. h (. p<. 0.001). No significant correlation between BNP levels and pulmonary capillary wedge pressures was found (. r=. 0.052; p=. 0.604). Conclusions: After cardiac surgery, BNP cannot be considered a reliable non-invasive surrogate for PCWP. In vivo, substantial BNP secretion occurs independently of PCWP in a setting of increasing intravascular volume and consciousness/sympathetic tone.

AB - Objective: In clinical cardiology, B-type natriuretic peptide (BNP) is used as a non-invasive surrogate marker for intra-cardiac filling pressures, particularly in patients with heart failure. It is unknown whether and to what extent increase in intravascular volume and/or sympathetic tone while maintaining constant intra-cardiac pressures leads to an increase in levels of BNP in vivo. Design and Methods: We aimed to test this hypothesis in an experimental in vivo model of patients directly after off-pump coronary artery bypass grafting admitted to the intensive care unit. These patients require high volumes of intravenous fluids titrated to keep intra-cardiac filling pressures and arterial blood pressure in the normal range while awakening from deep general anesthesia. In 27 consecutive patients, intra-cardiac filling pressures (using a pulmonary artery catheter) and levels of BNP were measured simultaneously every 6. h. Results: At 0, 6, 12, and 18. h, the pulmonary capillary wedge pressure remained constant (12. ±. 4, 13. ±. 3, 12. ±. 3, and 13. ±. 3. mmHg, respectively; p=. 0.351). Similarly, right heart filling pressures did not change during the study period. In contrast, BNP levels increased significantly during the study period: Median levels were 82 [IQR 37-162] pg/ml at 0. h, 153 [92-246] pg/ml at 6. h, 274 [156-392] pg/ml at 12. h, and 320 [200-528] pg/ml at 18. h (. p<. 0.001). No significant correlation between BNP levels and pulmonary capillary wedge pressures was found (. r=. 0.052; p=. 0.604). Conclusions: After cardiac surgery, BNP cannot be considered a reliable non-invasive surrogate for PCWP. In vivo, substantial BNP secretion occurs independently of PCWP in a setting of increasing intravascular volume and consciousness/sympathetic tone.

KW - BNP

KW - Cardiac surgery

KW - Endocrinology

KW - Intra-cardiac pressure

KW - Volume

UR - http://www.scopus.com/inward/record.url?scp=84925518263&partnerID=8YFLogxK

U2 - 10.1016/j.clinbiochem.2014.12.010

DO - 10.1016/j.clinbiochem.2014.12.010

M3 - SCORING: Journal article

C2 - 25526883

AN - SCOPUS:84925518263

VL - 48

SP - 318

EP - 321

JO - CLIN BIOCHEM

JF - CLIN BIOCHEM

SN - 0009-9120

IS - 4-5

ER -